Abametapir and Thiotepa: Interaction Details
- Thiotepa
- TepadinaTepylute
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Abametapir and Thiotepa interaction:
Abametapir
We don't have a drug information page for Abametapir because it is no longer sold in the US: the FDA lists every approved version as discontinued. Have a question about Abametapir? Ask a pharmacist, free →
Thiotepa
- Tepadina
- Tepylute
We don't have a drug information page for Thiotepa yet. Have a question about Thiotepa? Ask a pharmacist, free →
What Happens When You Take Abametapir With Thiotepa
What can happen when they are taken together (rated Major)
Increased exposure of
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
For a period of 2 weeks following the use of abametapir, CYP3A4 substrates should not be administered. When that is not possible, abametapir itself should be avoided.1
The Abametapir and Thiotepa Interaction, Explained
Abametapir is a lotion used to treat head lice. Even though it goes on your scalp, a little can get into your body and briefly block a liver enzyme called that helps break down many other medicines.
Thiotepa is a chemotherapy medicine that your body clears using that same enzyme. If the enzyme is blocked, thiotepa could build up higher than expected, which may raise the risk of side effects. This concern is based on how the drugs work rather than on real-world reports, but because thiotepa is a serious cancer drug, doctors take it seriously. The good news: your care team can plan the timing and manage this safely, so talk with them before using both.
Mechanism: Abametapir is a ; thiotepa is a CYP3A4 . can decrease thiotepa , increasing systemic exposure (/) and toxicity risk.
- Direction: Increased thiotepa exposure and effect.
- Onset: Rapid; enzyme inhibition persists for up to ~2 weeks after a single topical application.
- Evidence: Theoretical, based on abametapir's known CYP3A4 inhibition.
- Severity: Major, given thiotepa's cytotoxic profile and narrow safety margin.
Management: Avoid CYP3A4 substrates, including thiotepa, within 2 weeks after abametapir application. If is unavoidable, avoid abametapir. Coordinate timing and monitoring through the oncology team.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Abametapir and Thiotepa Interact
The likely mechanism
of -mediated by abametapir
How to Manage the Abametapir and Thiotepa Interaction
Both medicines are important, so the goal is safe timing rather than stopping treatment on your own.
- Keep taking your prescribed chemotherapy and do not start or stop anything without your team.
- Tell your oncology team and pharmacist before using abametapir lice lotion, since its effect on the liver enzyme can last about 2 weeks.
- Your care team will typically separate the timing (avoid the lotion within 2 weeks of thiotepa) or choose a different lice treatment if needed.
- They may also monitor you more closely for chemotherapy side effects if both are used.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Abametapir or Thiotepa need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Abametapir and Thiotepa: Common Questions
How serious is the Abametapir and Thiotepa interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Abametapir and Thiotepa interaction managed?
Both medicines are important, so the goal is safe timing rather than stopping treatment on your own. Keep taking your prescribed chemotherapy and do not start or stop anything without your team. Tell your oncology team and pharmacist before using abametapir lice lotion, since its effect on the liver enzyme can last about 2 weeks. Your care team will typically separate the timing (avoid the lotion… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "rapid". Effects can appear quickly, often within about 24 hours of combining the drugs.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Abametapir and Thiotepa Interaction
Ask in your own words about taking Abametapir and Thiotepa together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: XEGLYZE(TM) topical lotion, abametapir topical lotion. Dr Reddy’s Laboratories Inc (per FDA), Princeton, NJ, 2020. DailyMed
Other Serious Interactions of Abametapir and Thiotepa
Also serious with Abametapir
Also serious with Thiotepa
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Abametapir
- Green TeaModerate
- CannabisModerate
- YohimbeModerate
- Black TeaModerate
- Pu-erh TeaModerate
- AdrafinilModerate
- Cannabidiol (CBD)Moderate
- Cannabinol (CBN)Moderate
- + 14 more
With Thiotepa
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- Vitamin CModerate
- Vitamin EModerate
- GingerModerate
- TurmericModerate
- Black PepperModerate
- + 143 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs. This interaction.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.